Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22534
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPoh, Ashleigh R-
dc.contributor.authorDwyer, Amy R-
dc.contributor.authorEissmann, Moritz F-
dc.contributor.authorChand, Ashwini L-
dc.contributor.authorBaloyan, David-
dc.contributor.authorBoon, Louis-
dc.contributor.authorMurrey, Michael W-
dc.contributor.authorWhitehead, Lachlan-
dc.contributor.authorO'Brien, Megan-
dc.contributor.authorLowell, Clifford A-
dc.contributor.authorPutoczki, Tracy L-
dc.contributor.authorPixley, Fiona J-
dc.contributor.authorO'Donoghue, Robert Jj-
dc.contributor.authorErnst, Matthias-
dc.date2020-01-28-
dc.date.accessioned2020-02-04T03:22:14Z-
dc.date.available2020-02-04T03:22:14Z-
dc.date.issued2020-04-
dc.identifier.citationCancer Immunology Research 2020; 8(4): 428-435-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/22534-
dc.description.abstractPersistent activation of the latent transcription factor STAT3 is observed in gastric tumor epithelial and immune cells and is associated with a poor patient prognosis. Although targeting STAT3-activating upstream kinases offers therapeutically viable targets with limited specificity, direct inhibition of STAT3 remains challenging. Here we provide functional evidence that myeloid-specific hematopoietic cell kinase (HCK) activity can drive STAT3-dependent epithelial tumor growth in mice and is associated with alternative macrophage activation alongside matrix remodeling and tumor cell invasion. Accordingly, genetic reduction of HCK expression in bone marrow-derived cells or systemic pharmacologic inhibition of HCK activity suppresses alternative macrophage polarization, epithelial STAT3 activation, and impairs tumor growth. These data validate HCK as a molecular target for the treatment of human solid tumors harboring excessive STAT3 activity.-
dc.language.isoeng-
dc.titleInhibition of the SRC kinase HCK impairs STAT3-dependent gastric tumor growth in mice.-
dc.typeJournal Article-
dc.identifier.journaltitleCancer immunology research-
dc.identifier.affiliationCancer and Inflammation, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine at La Trobe University-
dc.identifier.affiliationMasonic Cancer Center, University of Minnesota-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute-
dc.identifier.affiliationCancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine-
dc.identifier.affiliationBioceros, CM Utrecht-
dc.identifier.affiliationMedical Biology, The Walter and Eliza Hall Institute-
dc.identifier.affiliationCancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine-
dc.identifier.affiliationLaboratory Medicine, University of California, San Francisco-
dc.identifier.affiliationInflammation Division, Walter and Eliza Hall Institute of Medical Research-
dc.identifier.affiliationDepartment of Pharmacology and Therapeutics, University of Melbourne-
dc.identifier.affiliationSchool of Biomedical Sciences, University of Western Australiaen
dc.identifier.doi10.1158/2326-6066.CIR-19-0623-
dc.identifier.orcid0000-0002-1245-729X-
dc.identifier.orcid0000-0002-4388-9642-
dc.identifier.orcid0000-0002-1571-2532-
dc.identifier.orcid0000-0002-6399-1177-
dc.identifier.pubmedid31992566-
local.name.researcherChand, Ashwini L
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

26
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.